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Abstract Supercritical carbon dioxide processing of
poly-L-lactide (PLLA)/hydroxyapatite (nHA) nanocom-
posites was investigated as a means to prepare foams
suitable as scaffolds in bone tissue engineering applica-
tions. For given foaming parameters, addition of nHA to
the PLLA gave reduced cell sizes and improved homoge-
neity in the size distribution, but did not significantly affect
the degree of crystallinity, which remained of the order of
50 wt% in all the foams. The compressive modulus and
strength were primarily influenced by the porosity and
there was no significant reinforcement of the matrix by the
nHA. The mechanical properties of the foams were nev-
ertheless comparable with those of trabecular bone, and by
adjusting the saturation pressure and depressurization rate
it was possible to generate porosities of about 85 %, an
interconnected morphology and cell diameters in the range
200–400 lm from PLLA containing 4.17 vol% nHA, sat-
isfying established geometrical requirements for bone
replacement scaffolds.
1 Introduction
About 106 fractures are reported annually in the USA
alone, of which 500,000 (typically hips, ankles or tibia)
require bone grafts [1], and the bone graft and bone sub-
stitute market was worth about $1.5 billion in 2000 [2].
Autografts are attractive in terms of osteoconductivity
(provision of a suitable environment for bone forming cells
(osteblasts) [3]), and lead to lower rejection rates and
pathogen transmission than allo- or xenografts. Use of
autografts is nevertheless declining owing to limited
availability, pain/complications, long operating times and
blood loss during surgery to extract the graft. The bone
graft substitute market has hence undergone rapid expan-
sion, but there remains an urgent demand for improved
synthetic bioresorbable materials with appropriate mor-
phologies (interconnected porosity in the range 50–90 %,
pore diameters of 200–400 lm [4, 5]) and degradation
rates [6, 7], and mechanical properties close to those of
natural bone.
Poly-L-lactide (PLLA) is a semicrystalline thermoplastic
widely used in biomedical applications owing to its bio-
compatibility and biodegradability [6, 8–14]. It is currently
under consideration for use in porous biodegradable scaf-
folds for bone repair, but to improve osteoconductivity it is
of interest to modify such constructs with bioactive
ceramics (‘‘bioceramic’’) such as hydroxyapatite (HA) [15,
16]. A recent trend is to exploit the improved properties of
polymer/bioceramic nanocomposites. Here, the modifier
particles are comparable in size to those in natural bone,
which consists of around 60 wt% ceramic inclusions,
similar to HA in composition and structure, embedded in a
polymer (collagen) matrix [17–19]. Nanocrystalline HA
(nHA), for example, shows enhanced osteoblast adhesion,
and surface deposition of calcium-containing materials,
and enhanced osteoconduction when introduced into a
polymer matrix [1, 20, 21].
Efforts have been made to produce porous polymer/
bioceramic constructs by solvent casting/particulate leach-
ing, thermally induced phase separation or emulsion freeze
drying [22–24]. However, these approaches typically
involve organic solvents, which is a problem for
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implementation [25], providing a strong driving force for the
development of solvent-free processing techniques [11–14,
26], such as supercritical fluid foaming [27, 28]. In super-
critical fluid foaming, pressure and temperature control is
determinant for the growth and stabilization of a cellular
morphology and hence the final properties of the material,
which may also vary with filler content, crystallinity, and
fluid content [27, 29]. Filler addition generally induces het-
erogeneous cell nucleation owing to a local reduction in the
free energy of nucleation, and hence a decrease in average
cell size and an increase in cell density, as in polylactide/silk
fibroin foams [30], polylactide/layered silicate nanocom-
posite foams [31, 32], and other types of polymer/layered
silicate foams [33–36]. It may also influence the tensile
modulus and fracture toughness [37, 38], and the morphol-
ogy of semicrystalline polymers such as PLLA. Increases in
the spherulite nucleation density have already been reported
in PLLA in the presence of layered silicates [35] and nHA
[39], coupled with decreased spherulite growth rates, which
may be accounted for by strong increases in melt viscosity.
However, to the authors’ knowledge, the effect of well dis-
persed nHA on PLLA foams obtained by supercritical fluid
foaming has yet to be described in detail in the open litera-
ture. In what follows we present an investigation of the
feasibility of producing PLLA/nHA foams with a suitable
morphology for bone replacement using a new custom-built
autoclave for supercritical CO2 foaming. The goal was to
investigate the effects of foaming parameters and nHA
content on the morphology, density, cell size, crystallinity
and mechanical behavior, so as to identify appropriate con-
ditions for the preparation of foams suitable for clinical
testing as bone replacement scaffolds.
2 Experimental
Bioresorbable PLLA, intrinsic viscosity 1.6 dL/g
(Boehringer Ingelheim, Germany), was provided as flakes
and dried overnight at 75 C under vacuum prior to use.
Studies of PLLA with comparable intrinsic viscosity by gel
permeation chromatography indicate a polydispersity of 1.5
and a weight average molar mass, Mw, of about 150,000 g/
mol, which decreases by approximately 10 % after pro-
cessing under conditions equivalent to those described below
[40]. Hydroxyapatite nanopowder (nHA, nominal mean
diameter\200 nm from BET analysis, Sigma-Aldrich) was
used without further purification or treatment.
Prior to foaming, a homogeneous mixing of nanoparticles
and PLLA was achieved by melt-extrusion. PLLA and nHA
were compounded under dry nitrogen using a miniextruder
equipped with twin conical co-rotating screws and a capacity
of 5 cm3 (DSM Micro 5 compounder, Netherlands). A screw
rotation rate of 110 rpm, a temperature of 200 C and a
residence time of 4 min were used to prepare PLLA com-
pounds containing 0, 2 and 4.17 vol% of nHA in granulate
form, which were subsequently stored at -18 C (at higher
nHA contents, it became difficult to introduce the dry mix
into the extruder). These conditions led to uniform disper-
sions of the nHA particles in the PLLA matrix as demon-
strated elsewhere [39] (90 vol% of the particles had a
diameter less than 980 nm and 50 vol% had a diameter less
than 360 nm). Approximately 5 g of the compounded
PLLA/nHA granulate was then loaded into an open cylin-
drical mold (25 mm in diameter and 35 mm in height) and
foamed using a high-pressure, high-temperature autoclave
(SITEC-Sieber Engineering, Switzerland).
In initial tests, the same nominal process parameters
(saturation pressure (Psat) 200 bar, and saturation temper-
ature (Tsat) 200 C) were used as in studies with an earlier
autoclave [11]. However, the new autoclave incorporated a
range of improvements with regard to the control of foam
morphologies and properties, including systems to limit
temperature gradients in the chamber, which can lead to
uncontrolled microstructural gradients, and more precise
pressure and temperature control. It was therefore neces-
sary to adjust the process parameters in the present case, a
nominal Tsat of 200 C, for example, leading to too low a
melt viscosity, excessive collapse of the pores and highly
inhomogeneous microstructures. Tsat was therefore
decreased to 175 C and 165 C and Psat was varied
between 100 and 250 bars. Although these Tsat are below
the nominal melting point of the as-received PLLA (about
180 C), they remain well above the melting point of
PLLA in the presence of CO2 at comparable pressures
(about 130 C [41, 42]). Tsat and Psat were maintained for
10 min to allow adequate diffusion of the supercritical CO2
into the molten PLLA. Foam expansion was then achieved
by pressure release, controlled by a back-pressure regula-
tor, with additional oil cooling. Representative temperature
and pressure processing curves are shown in Fig. 1 and the
range of processing parameters investigated are given in
Table 1. The depressurization rates, dP/dt, and the asso-
ciated cooling rates, dT/dt (which could not be controlled
independently with the present set-up), were calculated
from the slope of P(t) in the range 200–250 to 50 bars and
of T(t) in the ranges 175–165 C to 100 C and 100–75 C.
At lower P, the depressurization rate dropped to
0.2–0.6 bar/s for all the foams, regardless of the conditions.
The morphology of the foams was observed by scanning
electron microscopy (SEM, Philips XL30) at a tension of
3 kV in secondary electron mode. Sections were taken
perpendicular to the foaming direction (see Fig. 2) and
coated with carbon. The dispersion of the nHA in the foam
walls and at the foam wall surfaces was also investigated
by transmission electron microscopy (TEM, Philips CM12)
at 100 kV. The foams were embedded in an epoxy resin.
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80 nm thick sections were then prepared from the resulting
blocks using an ultramicrotome (Reichert-Jung Ultracut-E)
at ambient temperature with a 35 diamond knife
(Diatome) and mounted on formvar/carbon covered copper
TEM grids.
X-ray micro-computed tomography (lCT) was also used
for systematic morphological characterization of selected
foams [12, 43–46]. The measurements were performed
using a Skyscan 1076 micro-CT scanner (Skyscan). Five
cylindrical specimens (3 mm in diameter and 3 mm in
height) were cut from the foams and scanned at 42 kV,
with an intensity of 242 lA, an exposure time of 800 ms,
and a spatial resolution of 9 lm, without a filter. The
reconstruction and analysis were carried out using
Geomagic, NRecon and CTan software (Skyscan). A sec-
ond order polynomial correction was used to reduce beam-
hardening effects.
The foam densities were measured by weighing cylinders
with a height of 8 mm and a diameter of 8 mm cut from the
foams (Fig. 2). The porosity (e*) was evaluated from
Fig. 1 Representative a pressure and b temperature profiles during CO2 supercritical foam processing (in this case for foam B)
Table 1 Foaming parameters
Specimen
designation
Saturation
temperature (C)
Saturation
pressure (Bar)
Depressurization
rate (Bar/s)
Cooling rate from
Tsat to 110 C (K/s)
Cooling rate from
110 to 75 C (K/s)
A 175 100 4.8 1.2 0.04
B 175 200 10.6 2.5 0.05
C 175 200 16.5 4.5 0.04
D 175 200 21.1 5.6 0.035
E 165 200 2.6 1.16 0.03
F 165 200 5.8 2.2 0.03
G 165 200 12.2 3.8 0.02
H 165 250 5.8 2 0.03
I 165 250 11.6 3.8 0.05
Fig. 2 a Schematic
representation showing foaming
direction in the mold (indicated
by the arrow) and the geometry
of the cylindrical specimens
used for density measurements
and compressions tests,
b images of the as-molded foam
(left) and the cylindrical
specimens (right)
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qs ¼ Vf qf þ Vpqp ð1Þ
e ¼ 1  q
qs
ð2Þ
where qs is the density of the bulk composite, qf and qp are
the densities, and Vf and Vp are the volume fractions of the
nHA and PLLA respectively. At least five specimens were
characterized for each set of foaming conditions.
The influence of the nHA on the dynamic rheological
properties was studied using an Advanced Rheometric
Expansion System (ARES) (Rheometrics Europe GmbH).
The measurements were performed in dynamic oscillatory
shear mode using 25 diameter parallel plates. Frequency
sweeps from 0.1 to 100 rad/s were carried out on 1 mm
thick, 25 mm diameter compression molded discs at 10 %
strain, which is in the linear viscoelastic range. The mea-
surements were performed in triplicate to check for
reproducibility.
Thermal properties were determined by differential
scanning calorimetry (DSC, TA Instruments Q100).
Specimens of approximately 3 mg were cut from the foams
and placed in aluminum pan. They were held at 30 C for
1 min and then heated at 10 K/min to 210 C. The degree
of crystallinity of the matrix, Xc, was determined in each
case from
Xc ¼ DH
DH0f 1  WnHAð Þ
: ð3Þ
where DH was estimated from the total enthalpy change in
heating scans with respect to an interpolated baseline
between Tg and a temperature of about 20 K above the final
melting point Tm, and DHf
0 is the melting enthalpy per unit
mass of an infinitely large crystal of the a phase of PLLA,
taken to be 91 J/g [47]. Degrees of crystallinity and crys-
tallization rates under non-isothermal conditions were
determined using circular specimens of approximately
3 mg cut from a 200 lm thick compression-molded sheet.
These were held at 210 C for 1 min to erase the effects of
the prior thermal history, cooled at different rates to 10 C
and rescanned to 210 C at 10 K/min, in order investigate
the subsequent melting behavior.
The tensile behavior of ‘‘dog-bone’’ specimens injection
molded from the bulk composites (thickness of 2 mm, gage
width of 4 mm and gage length of 22 mm) and the com-
pression behavior of cylindrical specimens with a height of
8 mm and a diameter of 8 mm cut from the foams (Fig. 2)
were evaluated using a Universal Testing Machine (UTS
Test System, Germany) at cross-head speeds of 3 mm/min
and 0.5 mm/min, respectively. Three to five specimens were
tested for each set of conditions. The Young’s moduli, Es, of
the bulk composites and the compressive moduli, E*, of the
foams, were evaluated from the initial linear elastic part of
stress–strain curves. The tensile strength, r, and the
compressive strength, r*, denoted rel* in the case of flexible
foams and rpl* in the case of plastic foams, were taken to
correspond to the first maximum in the stress–strain curves.
3 Results and discussion
3.1 Rheology of the PLLA/nHA blends
Figure 3 shows the complex viscosity, g*, of pure PLLA,
PLLA/2 vol% nHA and PLLA/4.17 vol% nHA at 190 C
as a function of angular frequency, x. A Newtonian plateau
was observed between about 0.3 rad/s and 10 rad/s for all
the materials, but there was a significant increase in the
absolute values of g* with increasing nHA content, g*
more than doubling on addition of 2 vol% nHA.
3.2 Dispersion of the nHA in the foam cell walls
Figure 4 shows TEM micrographs from the cell walls of
foams prepared from PLLA/2 and 4.17 vol% nHA. All the
images indicated well dispersed individual nanoparticles,
and there was no evidence for particle segregation, such as
might have been induced by preferential matrix expansion
in regions of locally reduced nHA content, given the
dependence of the viscosity on the global nHA content.
Moreover, significant numbers of nHA particles were
present at the cell wall surfaces, which may contribute both
to the hydrophilicity of scaffold and to its osteoconduc-
tivity once implanted [1, 20, 21].
3.3 Foam morphology as a function of nHA content
and processing parameters
Figures 5, 6 show SEM micrographs from the surfaces of
PLLA foams containing 0, 2, and 4.17 vol% of nHA,
Fig. 3 Complex viscosity, g*, of PLLA and its nanocomposites at
190 C as a function of angular frequency, x
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produced under the conditions A to D and E to I, respectively,
as described in Table 1. A predominantly open cell structure
was observed in all the foams, but the foam architecture and
cell diameter varied depending on the nHA content and the
processing parameters. Thus, with Psat = 100 bar, the cell
diameter decreased from roughly 1–2 mm for the neat PLLA
(Fig. 5a) to 0.8–1 mm in the presence of nHA (Fig. 5b, c),
and with Psat = 200 bar (Fig. 5d–l), addition of nHA
resulted in a decrease in cell diameter from roughly
0.5–1 mm to 150–400 lm. Increasing the nHA content
further from 2 to 4.17 vol% had relatively little effect on the
cell diameters under these conditions, although the cell
diameters appeared somewhat less uniform at 4.17 vol%
nHA than at 2 vol% nHA. A similar but less marked trend
was observed at Psat = 250 bar (Fig. 6j–l), the cell diameter
decreasing from 150–500 to 100–400 lm as the nHA content
was increased. Finally, as shown in Fig. 7, the foam density
also tended to increase with increasing nHA content (from
0.13 to 0.19 g/cm3 for foam D, for example). Limited gas
expansion owing to the increase of g* with nHA content may
explain the reduction in porosity and cell diameter [11, 30,
32–35]. Moreover, it is known that fillers can act as effective
heterogeneous nucleation sites for cell formation, increasing
the number of cells per unit volume and leading to a more
uniform cell diameter (assuming uniform dispersion of the
filler) [34, 48].
The cell diameter may also be inferred from the results
in Figs. 5, 6 to decrease with decreasing Tsat. For example,
the morphologies of foams B and G, processed at different
Tsat (175 and 165 C, respectively) but similar Psat
(200 bar) and dP/dt (10.65 or 12.2 bar/s) (foam B, Fig. 5d–
f), and foam G, Fig. 6d–f), were significantly different,
foams G showing a more uniform architecture and smaller
cell diameters than foam B. This may again be be attributed
to an increase in viscosity, in this case with decreasing Tsat,
leading to a decrease in the extent of cell growth and
coalescence [32, 33]. Even so, the densities of foams B and
G were not significantly different.
Fig. 4 TEM micrographs of foam wall of a PLLA/2 vol% nHA and b, c PLLA/4.17 vol% nHA. Example of nHA particles at the foam wall
surface are indicated by arrows
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For foams F and H (Fig. 6d–f, j–l) and foams G and I
(Fig. 6g–i), m–o), Tsat and dP/dt were similar, but Psat
varied between 200 and 250 bar. According to Henry’s
law, the CO2 concentration in the polymer prior to
depressurization should be proportional to Psat, so that any
increase in Psat is expected to result in an increased
nucleation density for a given depressurization rate and
nHA content [11, 30, 32, 49, 50]. This explains the slightly
higher foam densities (Fig. 7) and reduced cell diameters in
foams H and I compared with those in foams F and G (cell
diameters of 100–400 lm for foam I and 200–500 lm for
foam G) [11, 51]. It follows that the low foam densities and
large cell diameters in foam A were a consequence of the
relatively low Psat (100 bar) used in this case.
Increasing dP/dt from 10.6 bar/s (foam B) to 16.5 bar/s
(foam C) at Psat = 200 bar and Tsat = 175 C, did not lead
to significant differences in cell diameter and the unifor-
mity of the cell diameters for a given nHA content
Fig. 5 SEM micrographs of the surface of PLLA foams with 0, 2 and
4.17 vol% nHA, produced under the conditions shown in Table 1:
a–c foam A with 0, 2, and 4.17 vol% nHA; d–f foam B with 0, 2 and
4.17 vol% nHA; g–i foam C with 0, 2 and 4.17 vol% nHA; j–l foam
D with 0, 2 and 4.17 vol% nHA
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Fig. 6 SEM micrographs of the surface of PLLA foams with 0, 2,
and 4.17 vol% of nHA, produced under the conditions shown in
Table 1: a–c foam E with 0, 2 and 4.17 vol% nHA; d–f foam F with
0, 2 and 4.17 vol% nHA; g–i foam G with 0, 2 and 4.17 vol% nHA;
j–l foam H with 0, 2 and 4.17 vol% nHA; m–o foam I with 0, 2 and
4.17 vol% nHA
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(compare Fig. 5d, g), Fig. 5e, h), and Fig. 5f, i). However,
when the depressurization rate was increased further to
21.1 bar/s (foam D), the cell diameters increased some-
what and became highly non-uniform in all the materials
(Fig. 5j–l). A similar trend was shown by foams E, F and
G (Fig. 6), for which an increase in dP/dt from 2.6 to
12.2 bar/s again led to larger cell diameters and less
uniform foam architectures. Crystallization during gas
release is a possible contributing factor to the smaller cell
diameters and more uniform structures obtained at lower
dP/dt [26]. At the lowest dP/dt, and hence at the lowest
cooling rates (cf. Table 1), crystallization in the early
stages of gas release may restrict cell growth and stabilize
the morphology to a greater extent than at higher cooling
Fig. 7 a Foam densities and b porosities as a function of nHA content
Fig. 8 DSC heating scans of foams a A, b B, c C and d D with the nHA contents indicated
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rates. The evidence for this will be discussed further
below.
3.4 Crystallization behavior
Figure 8 shows representative DSC heating scans from
foams A to D. Very similar similar melting endotherms
were observed in all the foams, with a maximum, Tm, at
178–180 C, which was attributed to reorganization and/or
recrystallization during the heating scans [52], so that it did
not reflect the melting points of the lamellae originally
present after solidification. In foams A (Fig. 8a), E and H,
however, the main melting peak showed a low temperature
shoulder. This was most marked in the presence of nHA
and was assumed to reflect the initial presence of relatively
stable lamellae in these cases, which correspond to the
lowest maximum cooling rates [52–54]. The Continuous-
Cooling-Transformation (CCT) curves determined inde-
pendently by DSC shown in Fig. 9a–c) give the degree of
crystallinity as a function of time and cooling rate.
Crystallization generally occurred somewhat more rapidly
in the presence of nHA, owing to a small but significant
increase in the density of spherulite nucleation at a given
temperature or cooling rate [39]. The CCT curves were
assumed to provide some indication of the crystallization
rates during the foaming process, although one should bear
in mind: (i) the possible plasticizing effect of residual
dissolved CO2 after depressurization [41, 55, 56]; (ii) that
the temperatures measured inside the autoclave did not
necessarily give a precise indication of the local tempera-
tures within the PLA; (iii) the influence of deformation on
the crystallization rates [55, 57]. For the range of cooling
rates investigated, i.e. between 1.2 and 5.6 K/s from Tsat to
110 C and between 0.02 and 0.05 K/s below 110 C for
all foams, Fig. 9 suggests that there should be little crys-
tallization above 110 C in the quiescent state in the
absence of CO2. On the other hand, crystallization is
expected to occur readily below about 110 C, given that it
was observed in this temperature range in the DSC mea-
surements even at relatively high cooling rates. Lamellae
Fig. 9 Continuous-cooling-transformation (CCT) diagrams for a PLLA, b PLLA/2 vol% nHA, c PLLA/4.17 vol% nHA, d maximum degree of
crystallinity as a function of cooling rate for all materials
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formed under these conditions, i.e. at high degrees of
supercooling, are relatively unstable and hence prone to
reorganization and/or recrystallization during heating,
consistent with the DSC traces in Fig. 8 [39]. In the case of
foam A, the small exotherm in the temperature range
immediately below the main melting peak in the absence of
nHA (Fig. 8a), characteristic of a transformation from the
less stable a0 crystalline phase of PLLA to the a phase
during the scans, was again consistent with a crystallization
temperature B110 C [39]. Indeed, very similar thermal
Fig. 10 SEM micrographs of a neat PLLA foam A, b neat PLLA foam B, c PLLA/4.17 vol% nHA foam E, d PLLA/2 vol% nHA foam H
Fig. 11 Representative compressive stress–strain curves for foams a B and b E with the nHA contents indicated
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melting transitions were observed in a previous study, in
which PLLA/nHA films were crystallized isothermally at
110 C [58]. The DSC measurements did not reveal any
clear dependence of Xc on nHA content or processing
parameters, the measured Xc showing considerably more
experimental scatter (standard deviation of about ±5 %)
than systematic variation. The mean Xc was about 57 %,
broadly consistent with Xc of about 50 % obtained after
cooling PLLA and its nanocomposites at comparable rates
in the DSC (Fig. 9d).
SEM indicated transcrystallinity and equiaxed spherulites
to coexist for all the nHA contents and processing conditions
investigated (Fig. 10). The transcrystalline regions were
suggestive of deformation-induced crystallization [59],
taking place during, or immediately after foam expansion,
and hence to contribute to the overall structural integrity of
foams at high temperatures as suggested previously. It
follows that the equiaxed spherulites, which were generally
dominant, were formed well after foam expansion in the
relatively low cooling rate regime at 110 C and below. As
shown in the inset to Fig. 10b, local regions of the foams in
which apparently amorphous regions of PLLA subsisted
between spherulites were also occasionally encountered,
accounting for the large scatter in the measured Xc.
3.5 Compression tests
Representative compressive stress–strain curves, indicating
elastic–plastic deformation in each case according to the
classification of Gibson and Ashby, are given in Fig. 11
[60, 61]. The foams showed increased compression mod-
ulus E* and compressive strength r* with increasing nHA
content, but increasing the nHA content also tended to
decrease the porosity as seen in Fig. 7. To assess the
influence of these changes in porosity, the dependence of
E* and r* on relative density were modeled following
Gibson and Ashby [61]. For an isotropic cell structure,
E
ES
¼ C1;2 q

qS
 2
þ 1  ;ð Þ q

qS
 
: ð4Þ
where C1 is a constant of the order of one, Es is the
Young’s modulus of the matrix (Table 2) and q* and qs are
Table 2 Tensile modulus and yield strength of the bulk moldings
Young’s Modulus,
Es, (MPa)
Yield strength,
r, (MPa]
PLLA 3133 ± 328 58.7 ± 2.3
PLLA/2 vol% nHA 3135 ± 227 58.7 ± 1.4
PLLA/4.17 vol% nHA 3242 ± 198 57.9 ± 1.0
Fig. 12 a Compressive
modulus (E*) and
b compressive strength (r*) for
all the foams. In (a), the data are
compared with the predictions
of the Gibson model for open
and closed cells. In (b), the data
are compared with the
predictions of the Gibson model
for flexible and plastic foams
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the foam and matrix densities respectively. The fraction of
solid in the cell edges, Ø (the remaining fraction, 1-Ø, is
in the cell walls), was defined to be equal to one for open-
celled foams and was taken to be 0.8 for closed-cell foams
(20 % of the solid in the cell walls), based on typical values
for closed-cell foams from the literature [62, 63]).
For a flexible foam, which shows extensive non-linear
elasticity owing to elastic buckling of the cell walls, the
dependence of r* (denoted rel*) on relative density is
given by
r

el
ES
¼ 0:05 q

qS
 2
: ð5Þ
For a plastic foam, in which the cell walls yield
plastically, the dependence of r* (denoted rpl*) on relative
density is given by
rpl
r
¼ 0:3 q

qS
 3=2
: ð6Þ
E* and r* are shown in Fig. 12 for the various foams. The
data for E* (Fig. 12a) were closer to the predictions of
Gibson and Ashby’s model for open-cell foams than for
closed-cell foams, assuming constant Es (Eq. 5), consistent
with the SEM observations of predominantly open-cell
structures (Figs. 5, 6). Moreover, the similar dependence of
E* on porosity in all the foams indicated the nHA to have
little effect on E*, as expected given the very minor influence
of nHA on Es implied by the tensile test results in Table 2.
The trends in the compressive strength of the foams
(Fig. 12b) were less clear, the experimental data for r*
generally being intermediate between the model predic-
tions for flexible and plastic foam models. Nevertheless, r*
was clearly correlated with the porosity, again suggesting
the nanoparticles to have a minor influence. This contrasts
with results obtained elsewhere for polypropylene foams
modified with layered silicate clay, for example, addition
of 2 wt% clay leading to an increase in compression
modulus from 0.44–1.72 MPa at approximately constant
foam density [64]. Similar improvements in modulus have
been reported in polyurethane/clay nanocomposite foams
and polystyrene/carbon nanofiber nanocomposite foams
[29, 65]. However, in all these materials, the filler aspect
ratios were relatively high (platelets or fibers), and one
would therefore expect a relatively high degree of rein-
forcement compared with the present case of spherical
particles.
3.6 Suitability of the foams for bone replacement
It is generally considered than an ideal scaffold for the
growth of new bone tissue should be a three-dimensional
network with inter-connected pores. As stated in the
introduction, a porosity in the range of 50–90 % and cell
diameters in the range 200–500 lm are known to promote
the migration of cells and bone growth within the scaffold
[5]. The foams in the present study generally showed
porosities between 85 and 90 % (Fig. 7b) and an inter-
connected morphology, as shown in Figs. 5 and 6. The cell
diameters and homogeneity of the structures varied con-
siderably, but could be tuned by adjusting the foaming
Table 3 Structural parameters of foam E with 4.17 vol% nHA measured by lCT
Porosity, e* (%) Open porosity, e* (%) Specific surface (1/mm) Degree of anisotropy Cell diameter (lm) Cell wall thickness (lm)
76.97 ± 2.06 76.96 ± 2.03 32.9 ± 2.22 2.71 ± 0.30 362 ± 50.6 115 ± 7.34
Fig. 13 a 2D slice perpendicular to the foaming direction and b 3D lCT reconstruction of foam E with 4.17 vol% nHA
1382 J Mater Sci: Mater Med (2012) 23:1371–1385
123
parameters. In the present case, PLLA/4.17 vol% nHA
foam E (Psat = 200 bar, Tsat = 165 C and dP/
dt = 2.6 bars/s) was considered to be the most promising
structure for further investigation, showing cell diameters
in the range 300–500 lm and a homogenous structure, and
the highest concentration of nHA achievable with the
present processing route. The morphological parameters of
foam E with 4.17 vol% of nHA were investigated further
by lCT analysis, as summarized in Table 3 and Fig. 13,
which shows a 2D slice and a 3D reconstruction of a
representative sample from the foam. The mean cell
diameter obtained by lCT was consistent with cell diam-
eters determined from SEM micrographs. The porosity was
lower than calculated from the density measurements (77
as opposed to 85 %), but was still well within the required
range, and the dominance of open porosity suggested by
the SEM observations was confirmed. The structure also
showed significant anisotropy, as reflected by a measured
degree of anisotropy, defined as the ratio between the
maximal and minimal radius of the mean intercept length
(MIL) ellipsoid, of 2.7 (Table 3), and the 3D reconstruction
in Fig. 13, in which elongated pores oriented in the
foaming direction are visible, reminiscent of the mor-
phology of trabecular bone [12, 66].
The compressive modulus of foam E with 4.17 vol% of
nHA of 70 MPa was within the range of values cited for
trabecular bone (50–500 MPa), although the compressive
strength was somewhat lower (2.2 MPa as compared with
7–10 MPa for trabecular bone) [1, 8, 66–68]. The main
goal of adding nanoparticles in PLLA was not to improve
the mechanical properties, however, but to enhance bio-
activity, and biomechanical studies have already proven
the feasibility of using scaffolds with relatively modest
mechanical properties in clinical applications, such as
revision knee arthroplasty [69]. Moreover, significant
increases in both the modulus and compressive strength
may be obtained, if necessary, by incorporating continuous
biodegradable glass fibers into the foams [13, 14].
Owing to the lack of effective temperature control in the
critical regime for crystallization in the present set-up, the
matrix morphology was found to be relatively insensitive
to the processing conditions, spherulitic microstructures
and relatively high degrees of crystallinity being obtained
throughout. It was consequently difficult to assess directly
the extent to which crystallization was determinant for the
formation of stable foam structures and it will be difficult
on this basis to determine whether a spherulitic micro-
structure is ideal for the in vitro and in vivo response of the
foams. While amorphous PLLA crystallizes relatively
rapidly under physiological conditions, the initial degree of
crystallinity has been shown to be an important factor for
the degradation rate of PLLA [58, 70–72]. Moreover, as
shown in our previous work on PLLA/nHA films, coarse
spherulitic microstructures may result in more brittle
behavior after aging in vitro than initially amorphous films
that undergo cold crystallization during ageing, which
results in relatively homogeneous microstructures [58]. On
the other hand, it is not known whether this represents a
critical limitation for the application, and in vitro and in
vivo testing will be necessary to establish whether better
microstructural control is a practical requirement.
4 Conclusions
The aim of this study was to investigate the extent to which
the presence of nHA nanoparticles and foaming parameters
influence the morphology, crystallinity and mechanical
properties of PLLA/nHA nanocomposite foams intended
for use as bone replacement scaffolds. It was shown that
nHA addition resulted in a reduced cell size and more
homogeneous architecture, which were attributed to an
increased matrix viscosity and/or an increased cell nucle-
ation density. Increasing Psat also resulted in a reduced cell
size, again attributed to an increased nucleation density, in
this case due to the higher CO2 content prior to depres-
surization. Decreasing Tsat induced a more uniform archi-
tecture and a reduced cell size, again due to an increased
matrix viscosity and, finally, decreasing dP/dt improved
the stability of the structure and reduced the cell size. SEM
indicated transcrystallinity and equiaxed spherulites to
coexist for all the nHA contents and processing conditions
investigated, and the high degree of crystallinity of all the
foams was consistently high. This was argued to be due to
the insensitivity of the effective cooling rates in the tem-
perature range at which crystallization took place to the
process parameters. Given the lack of influence of the nHA
on the matrix mechanical properties, the compressive
modulus and strength of the foams were therefore deter-
mined primarily by the degree of porosity.
Foams produced from PLLA/4.17 vol% nHA at Psat
200 bar with depressurization rates of 2.6 bar/s were con-
sidered to be the most suitable for bone replacement on the
basis of their morphological parameters, showing intercon-
nected porosity of about 76 % as measured by lCT, cell
diameters in the 200–500 lm range and a homogeneous
structure. The next stage of the work will focus on evaluating
the biocompatibility through in vitro investigations of the
influence of the nHA content on the deposition of calcium-
containing minerals and the cell response. It will also be
important to verify whether the biological activity of the
PLLA/nHA foam is maintained during resorption.
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